Dataset Information

New predictive models of heart failure mortality using time-series measurements and ensemble models.

ABSTRACT: BACKGROUND:Morbidity and mortality rates associated with heart failure remain high. A wide variety of demographic and clinical factors as well as biomarkers are associated with increased mortality rates. Despite this, most multivariate predictive models for heart failure mortality have predictive accuracies characterized by a C-statistic (area under the receiver operating curve) of ?0.74. METHODS AND RESULTS:We analyzed data on 963 patients enrolled in the Vesnarinone Evaluation of Survival Trial (VEST), including circulating levels of 2 cytokines (tumor necrosis factor and interleukin-6) and their receptors sampled at baseline and at 8, 16, and 24 weeks. We built multivariate logistic regression models by using standard clinical variables and time-series of cytokine and cytokine receptor levels, using independent components analysis to handle collinearity among cytokine measurements, and L2-penalized stepwise regression for variable selection. We also built ensemble models with these data, using gentle boosting. Our multivariate logistic regression model using time-series cytokine measurements predicts 1-year mortality rates significantly better (P=0.001) than the baseline model, with a C-statistic of 0.81±0.03. Without the cytokines, the baseline model has a C-statistic of 0.73±0.03, and, with only baseline cytokine and cytokine receptor levels added, the model has a C-statistic of 0.74±0.04. An ensemble model of 100 decision stumps with serial cytokine measurements has a significantly better (P=0.04) C-statistic of 0.84±0.02. An ensemble model with baseline cytokine data and without the serial measurements has a C-statistic of 0.74±0.04. CONCLUSIONS:Significant gains in accuracy of one year mortality prediction in chronic heart failure can be obtained by using logistic regression models that incorporate serial measurements of biomarkers such as cytokine and cytokine receptor levels. Ensemble models capture inherent variability in large patient populations, and boost predictive accuracy through the use of time-series measurements.

SUBMITTER: Subramanian D

PROVIDER: S-EPMC3147114 | biostudies-literature | 2011 Jul

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

New predictive models of heart failure mortality using time-series measurements and ensemble models.

Subramanian Devika D Subramanian Venkataraman V Deswal Anita A Mann Douglas L DL

Circulation. Heart failure 20110511 4

<h4>Background</h4>Morbidity and mortality rates associated with heart failure remain high. A wide variety of demographic and clinical factors as well as biomarkers are associated with increased mortality rates. Despite this, most multivariate predictive models for heart failure mortality have predictive accuracies characterized by a C-statistic (area under the receiver operating curve) of ≈0.74.<h4>Methods and results</h4>We analyzed data on 963 patients enrolled in the Vesnarinone Evaluation o ...[more]

PMID: 21562057

Similar Datasets

Project description:AimsThis study aimed to review the performance of machine learning (ML) methods compared with conventional statistical models (CSMs) for predicting readmission and mortality in patients with heart failure (HF) and to present an approach to formally evaluate the quality of studies using ML algorithms for prediction modelling.Methods and resultsFollowing Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we performed a systematic literature search using MEDLINE, EPUB, Cochrane CENTRAL, EMBASE, INSPEC, ACM Library, and Web of Science. Eligible studies included primary research articles published between January 2000 and July 2020 comparing ML and CSMs in mortality and readmission prognosis of initially hospitalized HF patients. Data were extracted and analysed by two independent reviewers. A modified CHARMS checklist was developed in consultation with ML and biostatistics experts for quality assessment and was utilized to evaluate studies for risk of bias. Of 4322 articles identified and screened by two independent reviewers, 172 were deemed eligible for a full-text review. The final set comprised 20 articles and 686 842 patients. ML methods included random forests (n = 11), decision trees (n = 5), regression trees (n = 3), support vector machines (n = 9), neural networks (n = 12), and Bayesian techniques (n = 3). CSMs included logistic regression (n = 16), Cox regression (n = 3), or Poisson regression (n = 3). In 15 studies, readmission was examined at multiple time points ranging from 30 to 180 day readmission, with the majority of studies (n = 12) presenting prediction models for 30 day readmission outcomes. Of a total of 21 time-point comparisons, ML-derived c-indices were higher than CSM-derived c-indices in 16 of the 21 comparisons. In seven studies, mortality was examined at 9 time points ranging from in-hospital mortality to 1 year survival; of these nine, seven reported higher c-indices using ML. Two of these seven studies reported survival analyses utilizing random survival forests in their ML prediction models. Both reported higher c-indices when using ML compared with CSMs. A limitation of studies using ML techniques was that the majority were not externally validated, and calibration was rarely assessed. In the only study that was externally validated in a separate dataset, ML was superior to CSMs (c-indices 0.913 vs. 0.835).ConclusionsML algorithms had better discrimination than CSMs in most studies aiming to predict risk of readmission and mortality in HF patients. Based on our review, there is a need for external validation of ML-based studies of prediction modelling. We suggest that ML-based studies should also be evaluated using clinical quality standards for prognosis research. Registration: PROSPERO CRD42020134867.

Dataset Information

New predictive models of heart failure mortality using time-series measurements and ensemble models.

Publications

New predictive models of heart failure mortality using time-series measurements and ensemble models.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets